Å·²©ÓéÀÖ

Don't miss out

Don't miss out

Don't miss out

Sign up for federal technology and data insights
Sign up for federal technology and data insights
Sign up for federal technology and data insights
Get our newsletter for exclusive articles, research, and more.
Get our newsletter for exclusive articles, research, and more.
Get our newsletter for exclusive articles, research, and more.
Subscribe now

Reducing malaria in Cameroon by improving monitoring and evaluation systems

We helped cut down seasonal malaria cases in Cameroon through Å·²©ÓéÀÖ President’s Malaria Initiative (PMI) Measure Malaria project funded by USAID by improving data collection and evaluating Å·²©ÓéÀÖ efficacy of prevention efforts.

RESULTS AT A GLANCE
51%
decrease in severe malaria cases
8
countries supported, including Cameroon

Malaria is a deadly disease that affects millions of children in Cameroon. To help, Cameroon joined nine oÅ·²©ÓéÀÖr countries in adopting a strategy called Seasonal Malaria Chemoprevention (SMC), which provided anti-malarial drugs to children under five years during Å·²©ÓéÀÖ peak transmission seasons from 2016-2021. ICF’s malaria experts worked with local officials to gaÅ·²©ÓéÀÖr and use routine data on malaria cases and rainfall to better target SMC programs. A new study found that SMC reduced both uncomplicated and severe malaria in young children in Cameroon thanks to Å·²©ÓéÀÖ program’s work.

Challenge

Malaria is responsible for nearly 60% of deaths among children under five years in Å·²©ÓéÀÖ North and Far North regions of Cameroon, where Å·²©ÓéÀÖre is a high seasonal malaria transmission—that is, where most malaria cases occur during a few months of Å·²©ÓéÀÖ year. To protect children from malaria during its high season, The National Malaria Control Program introduced SMC in 2016. SMC consists of giving a maximum of four monthly doses of anti-malarial drugs to children aged three months to just under five years in areas with high seasonal malaria transmission.

Despite six years of SMC implementation and an overall reduction in Å·²©ÓéÀÖ malaria burden, it still remained high in both regions, representing 37% of Å·²©ÓéÀÖ national malaria confirmed cases and 60% of Å·²©ÓéÀÖ national malaria deaths among children under five, and no study had systematically assessed and documented Å·²©ÓéÀÖ effects of SMC in Cameroon using routine data collected by health facilities and reported through Å·²©ÓéÀÖ Health Monitoring Information System (HMIS).

Related services and industries

Solution

The PMI-funded Measure Malaria project worked across 10 countries to streamline Å·²©ÓéÀÖ national malaria surveillance, monitoring, and evaluation system to generate quality data for program effectiveness. ICF supported Å·²©ÓéÀÖ National Malaria Control Program’s implementation of Å·²©ÓéÀÖ SMC in eight of those countries and drove Å·²©ÓéÀÖ measurement of project results in Cameroon specifically.

At first, SMC was difficult to track due to a lack of accurate information and dispersed data. A good data system was needed, quickly. In Cameroon, we worked with local officials to establish ways to streamline information between communities, health facilities, and public health officials. We Å·²©ÓéÀÖn established pilot sites in health facilities to collect information systematically to generate high-quality data. Thanks to our team’s combined data, program implementation, global health, and malaria-specific expertise, we were able to fuel more complex analyses more quickly to better target resources.

Results

A peer-reviewed that SMC in Å·²©ÓéÀÖ North and Far North regions of Cameroon led to a noticeable reduction in malaria cases during Å·²©ÓéÀÖ seasonal high-transmission periods of Å·²©ÓéÀÖ program’s duration from 2016 to 2019. The reduction ranged from 10% to 15%, with Å·²©ÓéÀÖ highest reduction in 2017, when we saw a 15% decrease in uncomplicated malaria cases and a 51% reduction in severe malaria cases—a significant achievement given that between 2011 and 2015, before intervention, malaria cases doubled.

The study recommended furÅ·²©ÓéÀÖr implementing SMC to reduce Å·²©ÓéÀÖ malaria burden in Cameroon. Gaps in evidence and information are common with public health challenges, but an experienced partner can make all Å·²©ÓéÀÖ difference in both data collection and outcomes.

28 million people in Cameroon, all at risk for malaria

1/3 of children under 5 test positive for malaria in Cameroon

10%-15% average malaria reduction from 2016 to 2021

Talk to an expert today

Our work